Serotype distribution of <i>Streptococcus pneumoniae</i> and pneumococcal vaccine coverage in adults in Turkey between 2015 and 2018-Reference-Cited by-同舟云学术

Serotype distribution of Streptococcus pneumoniae and pneumococcal vaccine coverage in adults in Turkey between 2015 and 2018

Published:2022-12-29 Issue:1 Volume:55 Page:266-275
ISSN:0785-3890
Container-title:Annals of Medicine
language:en
Short-container-title:Annals of Medicine

Author:

Hascelik Gulsen¹^ORCID,Soyletir Guner²^ORCID,Gulay Zeynep³^ORCID,Sancak Banu¹^ORCID,Yaman Akgun⁴^ORCID,Gurler Nezahat⁵^ORCID,Aydemir Sabire Sohret⁶^ORCID,Bayramoglu Gulcin⁷^ORCID,Aydin Faruk⁷^ORCID,Cekin Yesim⁸^ORCID,Birinci Asuman⁹^ORCID,Ozakin Cuneyt¹⁰^ORCID,Akpolat Nezahat¹¹^ORCID,Ozhak Baysan Betil¹²^ORCID,Gultekin Meral¹²^ORCID,Zer Yasemin¹³^ORCID,Sanal Laser¹⁴^ORCID,Arabaci Cigdem¹⁵^ORCID,Ay Altintop Yasemin¹⁶^ORCID,Ozturk Candan¹⁷^ORCID,Ceyhan Mehmet¹⁸

Affiliation:

1. Department of Medical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey

2. Department of Medical Microbiology, Marmara University, Pendik Training and Research Hospital, Istanbul, Turkey

3. Department of Medical Microbiology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey

4. Department of Medical Microbiology, Faculty of Medicine, Cukurova University, Adana, Turkey

5. Department of Microbiology and Clinical Microbiology, Faculty of Medicine, Istanbul University, Istanbul, Turkey

6. Department of Medical Microbiology, Faculty of Medicine, Ege University, Izmir, Turkey

7. Department of Medical Microbiology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey

8. Department of Medical Microbiology, Antalya Training and Research Hospital, Antalya, Turkey

9. Department of Medical Microbiology, Faculty of Medicine, Samsun Ondokuz Mayıs University, Samsun, Turkey

10. Department of Medical Microbiology, Faculty of Medicine, Bursa Uludag University, Bursa, Turkey

11. Department of Medical Microbiology, Faculty of Medicine, Dicle University, Diyarbakir, Turkey

12. Department of Medical Microbiology, Faculty of Medicine, Akdeniz University, Antalya, Turkey

13. Department of Microbiology, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey

14. Department of Clinical Microbiology, Ankara Yuksek Ihtisas Training and Research Hospital, Ankara, Turkey

15. Department of Microbiology and Clinical Microbiology, Istanbul Prof. Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey

16. Department of Medical Microbiology, Kayseri City Training and Research Hospital, Kayseri, Turkey

17. Department of Medical Microbiology, Faculty of Medicine, Mersin University, Mersin, Turkey

18. Department of Pediatric Infectious Diseases, Faculty of Medicine, Hacettepe University, Ankara, Turkey

Funder

Pfizer Pharmaceuticals, Istanbul, Turkey

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07853890.2022.2160877

Reference35 articles.

1. Twenty-Year Public Health Impact of 7- and 13-Valent Pneumococcal Conjugate Vaccines in US Children

2. Pneumococcal infection in adults: burden of disease

3. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

4. Redefining risk categories for pneumococcal disease in adults: critical analysis of the evidence

5. Pneumococcal Vaccine as One of the Immunization Coverage Targets For Adulthood Vaccines: A Consensus Report of the Study Group For Adult Immunization of the Turkish Society of Clinical Microbiology and Infectious Diseases

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the pathogenesis and treatment of pneumococcal meningitis;Virulence;2024-08-27

2. Phenotypic and molecular characterization of Streptococcus pneumoniae serotype 3 isolates from blood and respiratory samples in Canada: CANWARD 2007–21;Journal of Antimicrobial Chemotherapy;2024-08-02

3. A Phase 3 Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine–Experienced Adults 50 Years of Age or Older (STRIDE-6);Clinical Infectious Diseases;2024-07-31

4. Development of a Recombinant Live Attenuated Influenza Vaccine Virus Expressing Pneumococcal Surface Antigen A as a Strategy for Combined Protection Against Influenza and Bacterial Coinfection Caused by Streptococcus pneumoniae;The Open Microbiology Journal;2024-06-25

5. Prime-boost-type PspA3 + 2 mucosal vaccine protects cynomolgus macaques from intratracheal challenge with pneumococci;Inflammation and Regeneration;2023-11-15